Implementing a community-based Parkinson’s Disease Wellness Program during COVID
Objective: The objective is to present a successful and safe community-based Parkinson’s Disease program during a worldwide pandemic. Background: The COVID-19 pandemic shut down most…iFall: Co-producing an instrumented application prototype for falls reporting in Parkinson’s disease
Objective: To work with those affected by Parkinson’s disease (PD) to co-produce a prototype of an instrumented application for reporting falls (iFall). Background: Falls commonly…Development of a remote physical exercise program during COVID-19 pandemic for individuals with Parkinson’s disease
Objective: To describe the development process of adaptation of in-person physical exercise program to telemonitoring format to people with Parkinson’s disease (PD). Background: People with…Life Satisfaction and Adaptation in Persons with Parkinson’s Disease
Objective: This study aimed to gain an in-depth understanding of the meaning of LS and adaptation in persons with PD. Background: Persons with Parkinson’s disease…Development of the Parkinson’s Disease Medication Adherence Scale (PD-MAS)
Objective: To implement the first 3 phases of the scale development process that will create the PD-MAS. Background: Drug therapy is a central strategy in…Anodic stimulation reduces corticospinal tract engagement in STN-DBS for Parkinson’s disease: a case report.
Objective: To seek how novel programming options modify the therapeutic window in a case of off-targeting DBS. Background: In Parkinson’s disease deep brain stimulation (DBS)…DBS Directional programming – Institution based study of programming in PD and ET patients
Objective: To examine the use of Deep Brain Stimulation (DBS) directional programming in Parkinson Disease (PD) and Essential Tremor (ET) patients Background: DBS and its utility…Metadata standards to support deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease (PD)
Objective: A metadata framework for Digital Health Technologies (DHT) to support enhanced regulatory maturity, and to facilitate standardization and harmonization of data collection Background: DHTs…Effect of dopaminergic treatment on digital sensor features in Phase II PASADENA Part 1 in early Parkinson’s disease
Objective: To characterize the sensitivity of smartphone and -watch sensor features to levodopa and dopamine agonist (DA-Tx) treatment. Background: Digital health technology tools (DHTTs) enable…Determining the content of a clinician-rated tool for freezing of gait severity
Objective: This study aimed to determine clinician’s ratings of the most important triggering circumstances to be examined and aspects of freezing of gait (FOG) to…
- « Previous Page
- 1
- …
- 281
- 282
- 283
- 284
- 285
- …
- 338
- Next Page »